152 related articles for article (PubMed ID: 15707670)
1. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Galineau L; Belzung C; Kodas E; Bodard S; Guilloteau D; Chalon S
Brain Res Dev Brain Res; 2005 Feb; 154(2):165-76. PubMed ID: 15707670
[TBL] [Abstract][Full Text] [Related]
2. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
Koprich JB; Chen EY; Kanaan NM; Campbell NG; Kordower JH; Lipton JW
Neurotoxicol Teratol; 2003; 25(5):509-17. PubMed ID: 12972064
[TBL] [Abstract][Full Text] [Related]
3. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
Johnson MP; Huang XM; Nichols DE
Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
5. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
Koprich JB; Campbell NG; Lipton JW
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
[TBL] [Abstract][Full Text] [Related]
6. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
Colado MI; Green AR
Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
9. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W
Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472
[TBL] [Abstract][Full Text] [Related]
11. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
[TBL] [Abstract][Full Text] [Related]
12. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
13. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
[TBL] [Abstract][Full Text] [Related]
15. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
Johnson M; Hanson GR; Gibb JW
Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain.
Meyer JS; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():373-80. PubMed ID: 12105113
[TBL] [Abstract][Full Text] [Related]
17. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
Schmidt CJ; Wu L; Lovenberg W
Eur J Pharmacol; 1986 May; 124(1-2):175-8. PubMed ID: 2424776
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
Gough B; Imam SZ; Blough B; Slikker W; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
Gough B; Ali SF; Slikker W; Holson RR
Pharmacol Biochem Behav; 1991 Jul; 39(3):619-23. PubMed ID: 1723797
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]